Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.


The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors endured a turbulent quarter, which propelled them to adjust their equity holdings so as to maintain their desired risk profile. As a result, the relevancy of these public filings and their content is indisputable, as they may reveal numerous high-potential stocks. The following article will discuss the smart money sentiment towards REGAL-BELOIT CORPORATION (NYSE:RBC).

REGAL-BELOIT CORPORATION (NYSE:RBC) shareholders have witnessed a decrease in activity from the world’s largest hedge funds recently. RBC was in 20 hedge funds’ portfolios at the end of September. There were 22 hedge funds in our database with RBC holdings at the end of the previous quarter. At the end of this article we will also compare RBC to other stocks including The Medicines Company (NASDAQ:MDCO), NorthWestern Corp (NYSE:NWE), and Prospect Capital Corporation (NASDAQ:PSEC) to get a better sense of its popularity.

Follow Regal Beloit Corp
Trade (RBC) Now!

To most market participants, hedge funds are viewed as worthless, outdated financial tools of yesteryear. While there are more than an 8,000 funds trading today, our experts look at the leaders of this group, about 700 funds. These investment experts preside over most of the smart money’s total capital, and by watching their finest picks, Insider Monkey has unsheathed numerous investment strategies that have historically beaten the market. Insider Monkey’s small-cap hedge fund strategy outpaced the S&P 500 index by 12 percentage points annually for a decade in their back tests.

Keeping this in mind, we’re going to take a glance at the key action surrounding REGAL-BELOIT CORPORATION (NYSE:RBC).

What does the smart money think about REGAL-BELOIT CORPORATION (NYSE:RBC)?

At the end of the third quarter, a total of 20 of the hedge funds tracked by Insider Monkey were bullish on this stock, a 9% slide from one quarter earlier. With hedge funds’ positions undergoing their usual ebb and flow, there exists a few notable hedge fund managers who were boosting their holdings significantly (or had already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Millennium Management, managed by Israel Englander, holds the biggest position in REGAL-BELOIT CORPORATION (NYSE:RBC). Millennium Management has a $45.7 million position in the stock, comprising 0.1% of its 13F portfolio. The second-largest stake is held by Fisher Asset Management, managed by Ken Fisher, which holds a $30.5 million position; 0.1% of its 13F portfolio is allocated to the stock. Some other members of the smart money with similar optimism contain Lee Munder’s Lee Munder Capital Group, Dmitry Balyasny’s Balyasny Asset Management, and Chuck Royce’s Royce & Associates.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.